[go: up one dir, main page]

AU8744691A - N-((2-thenoylmercapto-3-methyl)-butanoyl)-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it - Google Patents

N-((2-thenoylmercapto-3-methyl)-butanoyl)-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it

Info

Publication number
AU8744691A
AU8744691A AU87446/91A AU8744691A AU8744691A AU 8744691 A AU8744691 A AU 8744691A AU 87446/91 A AU87446/91 A AU 87446/91A AU 8744691 A AU8744691 A AU 8744691A AU 8744691 A AU8744691 A AU 8744691A
Authority
AU
Australia
Prior art keywords
thenoylmercapto
butanoyl
methyl
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87446/91A
Inventor
Giuseppe Quadro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medea Research SRL
Original Assignee
Medea Research SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medea Research SRL filed Critical Medea Research SRL
Publication of AU8744691A publication Critical patent/AU8744691A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

N-[(2-Thenoylmercapto-3-methyl)-butanoyl]-homocysteine thiolactone, the process for the preparation thereof and the use as therapeutic agent are described.
AU87446/91A 1990-11-12 1991-10-30 N-((2-thenoylmercapto-3-methyl)-butanoyl)-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it Abandoned AU8744691A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02201590A IT1246766B (en) 1990-11-12 1990-11-12 -
IT22015/90 1990-11-12

Publications (1)

Publication Number Publication Date
AU8744691A true AU8744691A (en) 1992-06-11

Family

ID=11190231

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87446/91A Abandoned AU8744691A (en) 1990-11-12 1991-10-30 N-((2-thenoylmercapto-3-methyl)-butanoyl)-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it

Country Status (6)

Country Link
EP (1) EP0557303B1 (en)
AT (1) ATE111461T1 (en)
AU (1) AU8744691A (en)
DE (1) DE69104058T2 (en)
IT (1) IT1246766B (en)
WO (1) WO1992008713A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6049796A (en) * 1995-06-07 1996-12-30 Fibromed, Inc. Lysyloxidase inhibitors
ATE221663T1 (en) * 1996-05-29 2002-08-15 Univ Mcgill PRION-BINDING PROTEINS AND THEIR USES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1212723A (en) 1915-11-16 1917-01-16 Thomas J Williams Coal-tipple.
IT1212723B (en) 1983-03-23 1989-11-30 Medea Res Srl Derivative of thiolactic acid for bronchosecretogenic activity.

Also Published As

Publication number Publication date
WO1992008713A1 (en) 1992-05-29
IT9022015A1 (en) 1992-05-12
ATE111461T1 (en) 1994-09-15
EP0557303B1 (en) 1994-09-14
EP0557303A1 (en) 1993-09-01
DE69104058T2 (en) 1995-04-06
DE69104058D1 (en) 1994-10-20
IT1246766B (en) 1994-11-26
IT9022015A0 (en) 1990-11-12

Similar Documents

Publication Publication Date Title
IL113084A0 (en) Thiazolidine and oxazolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SE9704545D0 (en) Novel compounds
SE9704544D0 (en) Novel compounds
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
NO178768C (en) 11-aryl-4-oestrenes and contraceptives containing them
AU631169B2 (en) Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
NO302368B1 (en) Quinoxaline compounds, pharmaceutical compositions containing them, and use of the compounds for the preparation of the preparations
IL95548A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
EP0515995A3 (en) N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
GB9025509D0 (en) New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
AU8744691A (en) N-((2-thenoylmercapto-3-methyl)-butanoyl)-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it
IL86173A0 (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
IL99389A0 (en) Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB9014532D0 (en) Thiazole compound,processes for the preparation thereof and pharmaceutical composition comprising the same
ZA943648B (en) Medicament aerosol formulation based on fusafungine a process for its preparation and pharmaceutical compositions containing it
GR910300116T1 (en) 3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them
FI945414A0 (en) Process for the preparation of N, N-disubstituted aminophenol
IL88161A0 (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ES2062940A1 (en) Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent
NZ240927A (en) Dibenz-oxa-thiocinones; preparatory processes, uses, and pharmaceutical compositions
IT1255380B (en) Nitrobenzoyl alanines, process for their preparation, their use as therapeutic agents and pharmaceutical compositions containing them
SI0695308T1 (en) Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
GB9012962D0 (en) New thiazole derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IT1269740B (en) Combretastatine derivatives having anti-tumoural activity and process for their preparation